# Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT

> **NCT04128917** · PHASE3 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 102 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** RAPAE01

## Key facts

- **NCT ID:** NCT04128917
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-21
- **Primary completion:** 2020-12-21
- **Final completion:** 2021-01-29
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2021-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04128917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04128917, "Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04128917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*